Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

60.69

+0.02 (0.03%)

as of Jul 23, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Jul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

HOLD

Fundamentally a great company. Got into trouble on guaranteed products. Should recover when the markets go up, which he thinks it will. You need 12-15 months of patience. Decent yield of 3.9%.

Wealthica Track your Stocks in your Watch List

DON'T BUY

If the caller had a 5 year or 10 year time horizon it might a Hold. Chart doesn't show much support until the stock gets back to the $9 range. Company stated they are waiting for markets and higher interest rates to help them out. This is not a great business plan.

HOLD

Have been issuing a lot of stock. When you keep diluting stock and taking on more debt, it puts out more danger signals. Has some confidence in management. As interest rates go up, this company will reprice mark to market, which will mean more profits. Would like to see it under $11.50.

COMMENT

Likes long-term outlook. Operationally doing well. Significant growth opportunities in Asia, primarily Vietnam and China. Biggest challenge is liability on variable annuities and segregated funds. Will be dependent on stock market growth (which he is optimistic on) as well as long-term interest rates, which will help.

DON'T BUY

Gives you a leveraged play on equity markets and on movement in long dated treasury yields. Prefers companies that are not correlated to broad equity markets. If you have a bullish outlook on equities and feel that long dated treasuries are going to start to back up significantly, this would work positively for them.

DON'T BUY

Earnings estimates have gone down significantly with an 83% negative earnings surprise in August. Very sensitive to equity markets.

COMMENT

In the process of becoming a great buy. Getting down to Book Value and a little below. There are worries they will do another equity raise but he doesn't know that they would do this down here. Could see $2 in earnings 2 years out. He is looking to get back into this one.

WAIT

The debate in his office is when does he double up on their present holdings. Core business is fine with good expansion plans in Asia, which will eventually work well for them. This company needs higher interest rates.

COMMENT

Chances of buying back shares are very, very slim. Major concern is their capital ratio, which is still comfortably ahead of the Superintendent of Insurance mandates. This one is a play on the market. If you are positive on the market, you have to own this one.

SELL ON STRENGTH

Had a number of negative activities. His market letter indicated the stock was heading to $10 except for a minor rally that may bring it to $14. Not a stock you want to own.

DON'T BUY

Pretty close to its Fair Market Value. Gut feeling is that it could trade down to its 2008-2009 low of around $8-$8.50.

DON'T BUY

It is hurt by low interest rates. They are a leveraged play on the US stock market.

HOLD

Has probably got very oversold. Still could be some problems with their equity products. Even with write-downs, the company has a good capital base. Had a good bounce recently and he thinks that will continue. 4% yield.

STRONG BUY

Stock market hates this one but the bond market is treating it as a strong going concern. Expecting they are going to have a much better Q3 as the stock market improves. Interest rates have nowhere to go but up. Trading below book value.

BUY

There will be some tax loss selling, which will put pressure on the stock. Disclosed last quarter that not only does it have equity risk because of lack of hedging, but also have US treasury interest rate risk if rates go down. A Buy at these prices.

Showing 1,411 to 1,425 of 2,283 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

John Stephenson

Stephenson & Company Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)